News and Insights

The latest news and insights from Genoa Healthcare.

  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Medication-assisted Treatment: Trends and Outcomes

For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD,...

  • Dec 20th, 2022
  • Behavioral Health
  • Clinical Insights
  • Treatment

New medication options in behavioral health

FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...

  • Jun 24th, 2022
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Long-Acting Injectable Antipsychotics in Practice

Treating Schizophrenia Long-acting injectable (LAI) antipsychotic formulations are being considered more often in the treatment of schizophrenia to promote medication adherence. Genoa Healthcare recently hosted a webinar providing an update...

  • Dec 9th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: New Medication Options in Behavioral Health

Behavioral Health Drug Updates This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including...

  • Oct 8th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: What Providers Need to Know: New Medication Options in Behavioral Health

Behavioral Drug Approvals in 2020 The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health...

  • Jul 6th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Substance Use Disorder and Medication Assisted Therapies

A Rise in Drug Overdoses Deaths from drug overdoses, which have climbed steadily over the past 20 years, rose sharply during the COVID-19 pandemic. This “epidemic within the pandemic” underscored...

  • Jun 30th, 2021
  • Behavioral Health
  • Clinical Insights
  • Treatment

Medication-assisted treatment and open communication achieve long-term results in treating PTSD

Medication-Assisted Treatment for PTSD Pharmacist Terri Taylor has worked behind the pharmacy counter for 32 years and has research experience at The University of Kansas School of Pharmacy. Over her...

  • Jun 9th, 2020
  • Behavioral Health
  • Clinical Insights
  • Treatment

Navigating Generic Drug Shortages in Behavioral Health

By Stephanie Kornechuk, Pharm D Senior Vice President, Procurement & Network Management, Genoa Healthcare Drug Shortages Affecting Behavioral Health Therapies New drug approvals have created new treatment options for those...

  • Sep 4th, 2019
  • Behavioral Health
  • Clinical Insights
  • Treatment

Pharmacies trial new role providing medication, care for opioid use disorder in Rhode Island Hospital study

This story was featured in the Boston Globe. Click here to read the article. Lifespan affiliate awarded $1.6M to help curb national opioid epidemic; will partner with pharmacy chain Genoa, treatment...

  • Mar 13th, 2019